Literature DB >> 21886741

A case of atypical pyoderma gangrenosum.

Ermira Vasili1, Entela Shkodrani, Liberta Labinoti, Alert Xhaja.   

Abstract

BACKGROUND: Pyoderma gangrenosum is a rare inflammatory disease of unknown etiology and unspecific histopathology. There are no clear-cut criteria for the diagnosis of this disease. The diagnosis is usually made based on clinical appereance, course of disease and possible, commonly coexisting disorders. In atypical cases the diagnosis is based on exclusion of other causes of similar appearing cutaneous ulcerations. MAIN OBSERVATIONS: The 67-year-old male patient, presented with a 15-year history of painful ulcers and vegetative lesions covered with sero-hemorrhagic and purulent secretions, localized on the dorsal surface of both hands leading to self-amputation of distal phalanges. We report a step-by-step The patient refers to have these complaints for more than 15 years. An extensive diagnostic procedure led to the diagnosis of pyoderma gangrenosum as a diagnosis of exclusion.
CONCLUSION: This report shows an atypical variant of an ulcerative disease. Pyoderma gangrenosum, a diagnosis of exclusion, was sustained based on an extensive diagnostic procedure. In this article we describe the step-by-step approach which let to this diagnosis.

Entities:  

Keywords:  P:G:; corticoterapi; diagnosis; ulcerative disease

Year:  2010        PMID: 21886741      PMCID: PMC3157807          DOI: 10.3315/jdcr.2010.1044

Source DB:  PubMed          Journal:  J Dermatol Case Rep        ISSN: 1898-7249


  13 in total

Review 1.  Diagnosis and treatment of pyoderma gangrenosum.

Authors:  Trevor Brooklyn; Giles Dunnill; Chris Probert
Journal:  BMJ       Date:  2006-07-22

Review 2.  Pyoderma gangrenosum: common pitfalls in management and a stepwise, evidence-based, therapeutic approach.

Authors:  Vimal Prajapati; Jeremy Man; Alain Brassard
Journal:  J Cutan Med Surg       Date:  2009 May-Jun       Impact factor: 2.092

3.  Development of pyoderma gangrenosum during therapy with infliximab.

Authors:  Natalia Jaimes-López; Verónica Molina; Juan E Arroyave; Luz A Vasquez; Ana C Ruiz; Rodrigo Castaño; Mario H Ruiz
Journal:  J Dermatol Case Rep       Date:  2009-08-24

4.  The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.

Authors:  C N Bernstein; J F Blanchard; P Rawsthorne; N Yu
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

Review 5.  Pyoderma gangrenosum: a review and update on new therapies.

Authors:  Jeremiah Miller; Brad A Yentzer; Adele Clark; Joseph L Jorizzo; Steven R Feldman
Journal:  J Am Acad Dermatol       Date:  2010-04       Impact factor: 11.527

Review 6.  Neutrophilic dermatoses.

Authors:  Jeffrey P Callen
Journal:  Dermatol Clin       Date:  2002-07       Impact factor: 3.478

Review 7.  Pyoderma gangrenosum: an updated review.

Authors:  E Ruocco; S Sangiuliano; A G Gravina; A Miranda; G Nicoletti
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-03-11       Impact factor: 6.166

8.  Pustular pyoderma gangrenosum.

Authors:  S Shankar; J C Sterling; E Rytina
Journal:  Clin Exp Dermatol       Date:  2003-11       Impact factor: 3.470

9.  Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease.

Authors:  Yoram Menachem; Israel Gotsman
Journal:  Isr Med Assoc J       Date:  2004-02       Impact factor: 0.892

Review 10.  Pyoderma gangrenosum--a review.

Authors:  Uwe Wollina
Journal:  Orphanet J Rare Dis       Date:  2007-04-15       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.